Inactive Instrument

Analyst Reco. Lpath, Inc. Nasdaq

Equities

US5489103060

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	CI
2023	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	23/23/23	MT
Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	04/23/04	MT
Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	30/22/30	MT
Stephens Adjusts Apollo Endosurgery's Price Target to $9 from $8, Keeps Overweight Rating	04/22/04	MT
Stifel Nicolaus Adjusts Apollo Endosurgery Price Target to $10 From $12, Maintains Buy Rating	23/22/23	MT
Piper Sandler Adjusts Apollo Endosurgery's Price Target to $12 From $14, Reiterates Overweight Rating	23/22/23	MT
Cowen Starts Apollo Endosurgery at Outperform With $13 Price Target	15/21/15	MT
Stifel Starts Apollo Endosurgery at Buy With $12 Price Target	09/21/09	MT
APOLLO ENDOSURGERY : Stephens Starts Apollo Endosurgery at Overweight with $15 Price Target	09/21/09	MT
APOLLO ENDOSURGERY : Lake Street Adjusts Apollo Endosurgery's Price Target to $14 From $12, Reiterates Buy Rating	04/21/04	MT
APOLLO ENDOSURGERY : Piper Sandler Adjusts Price Target on Apollo Endosurgery to $14 From $11, Maintains Overweight Rating	04/21/04	MT
APOLLO ENDOSURGERY : Piper Sandler Adjusts Apollo Endosurgery's Price Target to $11 From $9, Maintains Overweight Rating	14/21/14	MT
APOLLO ENDOSURGERY : Piper Sandler Adjusts Apollo Endosurgery's Price Target to $9 From $8.50, Maintains Overweight Rating	24/21/24	MT
APOLLO ENDOSURGERY : Lake Street Capital Starts Apollo Endosurgery at Buy With $12 Price Target	17/21/17	MT
APOLLO ENDOSURGERY : Piper Sandler Adjusts Apollo Endosurgery's Price Target to $8 From $7, Maintains Overweight Rating	22/21/22	MT
APOLLO ENDOSURGERY : Piper Sandler Upgrades Apollo Endosurgery to Overweight From Neutral	30/20/30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer